Highest-materiality recent filing
Privia Health shareholders elect all three Class I directors at 2026 annual meeting
Nancy Cocozza, David King, and Francis Soistman elected as Class I directors with over 99M votes each.
Privia Health Q1 revenue $603.8M (+25.8% YoY); adj EPS $0.19 (+18.8%)
Total revenue $603.8M (+25.8% YoY); gross profit $125.6M (+21.2%).
Privia Health beats 2025 guidance; revenue $2.12B, net income +59%, Adj. EBITDA $125.5M
Full-year revenue $2,122.8M, up 22.3% YoY; net income $22.9M, up 59.3% from 2024.
Privia Health Group completes acquisition of Accountable Care Organization from Evolent Health
Privia Health Group closed the acquisition of an Accountable Care Organization business from Evolent Health on December 5, 2025.
Privia Health Q3 net income surges 94%, revenue up 32.5%; raises FY25 guidance above high end
Revenue $580.4M (+32.5% YoY); net income $6.9M (+94.1%); operating income $14.4M (+147.8%).
Privia Health board member Patricia Maryland passes away
Patricia Maryland, Board member and Chair of the Compliance Committee, died on Oct 24, 2025.
Privia Health to acquire Evolent Health's ACO business for $100M cash, up to $113M with earnout
Acquires Evolent Health's ACO business covering over 120,000 attributed lives in MSSP and commercial MA programs.
Privia Health reports $233M MSSP savings, raises 2025 EBITDA guidance to $113-116M
Privia Health ACOs generated $233.1 million in Medicare Shared Savings Program savings for 2024, a 32% increase from 2023.
Privia Health Q2 revenue $521.2M (+23% YoY); guidance raised above prior range
Total revenue $521.2M, up 23.4% YoY; adjusted net income $30.6M ($0.24 EPS) vs $23.5M ($0.19 EPS) YoY.
Privia Health appoints Lance Berberian to board, adds tech and cybersecurity expertise
Appointed Lance Berberian to Class III director, effective July 15, 2025; board expands to 10 members.
Privia Health stockholders approve all three proposals at 2025 annual meeting
Directors Pamela Kimmet, Patricia Maryland, Shawn Morris elected with >102M votes each; broker non-votes ~4.8M.
Privia Health Q1 revenue up 15.6% to $480M; raises full-year outlook
Total revenue $480.1M (+15.6% YoY); GAAP net income $4.2M, GAAP EPS $0.03.
Base salary increases to $650,000 effective March 24, 2025.
Privia Health beats FY2024 guidance: revenue $1.74B, adj EPS $0.78, cash $491M, no debt
FY2024 revenue $1,736.4M (+4.7% YoY), gross profit $397.7M (+12.4%), net income $14.4M (-37.7%).
Privia Health furnishes investor slides at J.P. Morgan conference; no material updates disclosed
Furnished investor presentation for J.P. Morgan 2025 Healthcare Conference on January 13, 2025.
Privia Health raises FY2024 guidance, Q3 adjusted EPS $0.20, revenue $437.9M, up 4.9%
Q3 revenue $437.9M (+4.9% YoY); gross profit $99.9M (+10.2%); operating income $5.8M (+5.0%).
Privia Health Q2 revenue up 2.2% to $422.3M; raises FY2024 guidance
Q2 GAAP net income $3.5M ($0.03 EPS); adjusted net income $23.5M ($0.19 EPS), +13% YoY.
Privia Health director Bill Sullivan resigns from Board and Audit Committee
Bill Sullivan resigned from the Board and Audit Committee effective July 1, 2024.
Presentation provided at William Blair 44th Annual Growth Stock Conference on June 5, 2024.
Privia Health corrects overstated vote against advisory executive compensation proposal
Amendment corrects Proposal 2 vote: 96,616,303 For, 2,663,618 Against, 4,660,430 Abstentions.
Approved Second Amended Restated Charter removing supermajority voting provisions and limiting officer liability under Delaware law.
Privia Health Q1 revenue +7.5% to $415M; GAAP net income down 59% but adjusted EPS up 12.5%
Revenue $415.2M (+7.5% YoY); Practice Collections +7.4%; Implemented Providers +17.3%.
Privia Health FY2023 revenue up 22.2% to $1,657.7M, adjusted EPS $0.64; introduces 2024 outlook
Full-year revenue $1,657.7M (up 22.2% YoY); net income $23.1M vs loss $8.6M in 2022.
On July 1, 2024, Bill Sullivan resigned from his position as a member of the Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) and as a member of the Audit Committee of the Board, effective immediately.
Max materiality 0.85 · Median 0.65 · Most common event earnings